Tag: Junshi Biosciences
Junshi Biosciences Announces Financial Results for Six Months Ended June 30,...
Supplemental NDAs for Toripalimab filedExpanding into infectious disease and collaborating with IMCAS and Lilly for COVID-19 neutralizing antibodiesDual Listing on the STAR...
Nature Publishes Preclinical Characterization and Primate Efficacy Data on Junshi Biosciences’...
CB6 demonstrated prophylactic and treatment effects in rhesus monkeysClinical testing expected to begin in second quarter in collaboration with Eli Lilly and...
